ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

NCI Role, Issues In Education Considered By DRCCA Board

August 21, 1981

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

In Brief: Staff, Subcommittee Reports Due At NCAB June Meet; CCIRC to Sponsor Symposium On Epidemiology On Oct.

June 6, 1975